| 07 Aug 2026 | Diclofenac (Voltarol® Ophtha) 0.1% eye drops 0.3ml unit dose preservative-free | MSAN(2026)26 | Level 2 | mid-January 2027 | PDF ↗ |
| 24 Jul 2026 | Nifedipine 10mg, 20mg, 30mg and 60mg modified-release tablets | MSAN(2026)25 | Level 2 | various resupply dates apply. Please see below | PDF ↗ |
| 25 Jun 2026 | Disopyramide (Rythmodan®) 100mg capsules and disopyramide (Rythmodan | MSAN(2026)20 | Level 2 | early April 2027 for Disopyramide (Rythmodan®) 100mg and | PDF ↗ |
| 24 Jun 2026 | Propafenone (Arythmol®) 150mg tablets | MSAN(2026)19 | Level 2 | late July 2026 | PDF ↗ |
| 12 Jun 2026 | Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches - Update | MSAN(2026)18 | Level 2 | late September 2026 | PDF ↗ |
| 21 May 2026 | Trurapi® (insulin aspart) 100units/ml solution for injection 3ml pre-filled | MSAN(2026)17 | Level 2 | mid-June 2026 | PDF ↗ |
| 07 May 2026 | Midazolam (Epistatus®) 7.5mg/0.75ml oromucosal solution pre-filled oral syringes | MSAN(2026)16 | Level 2 | late-May 2026 | PDF ↗ |
| 27 Apr 2026 | Ramipril 1.25mg capsules | MSAN(2026)15 | Level 2 | end of May 2026 | PDF ↗ |
| 22 Apr 2026 | Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml | MSAN(2026)14 | Level 2 | noted products are being discontinued | PDF ↗ |
| 08 Apr 2026 | Cefixime (Suprax®) 200mg tablets | MSAN(2026)13 | Level 2 | mid-October 2026 | PDF ↗ |
| 02 Apr 2026 | Chlordiazepoxide 5mg and 10mg capsules | MSAN(2026)12 | Level 2 | mid-July 2026 | PDF ↗ |
| 06 Mar 2026 | Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free | MSAN(2026)11 | Level 2 | early June 2026 | PDF ↗ |
| 25 Feb 2026 | Sodium valproate (Epilim Chronosphere®) 100mg modified release granules | MSAN(2026)10 | Level 2 | mid-April 2026 | PDF ↗ |
| 25 Feb 2026 | Propafenone (Arythmol®) 150mg tablets | MSAN(2026)9 | Level 2 | early April 2026 | PDF ↗ |
| 18 Feb 2026 | Phenobarbital 30mg and 60mg tablets | MSAN(2026)8 | Level 2 | late March 2026 | PDF ↗ |
| 17 Feb 2026 | Lanreotide 60mg/0.5ml, 90mg/0.5ml and 120mg/0.5ml solution for injection pre- | MSAN(2026)7 | Level 2 | end of June 2026 | PDF ↗ |
| 13 Feb 2026 | Sulfadiazine silver (Flamazine®) 1% cream | MSAN(2026)6 | Level 2 | noted products are being discontinued | PDF ↗ |
| 30 Jan 2026 | Oxybutynin (Kentera®) 3.9mg/24hours transdermal patches | MSAN(2026)5 | Level 2 | late-February 2026 | PDF ↗ |
| 16 Jan 2026 | Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg | MSAN(2026)4 | Level 2 | product has been discontinued | PDF ↗ |
| 14 Jan 2026 | Co-codamol 30mg/500mg tablets | MSAN(2026)3 | Level 3 | early June 2026 | PDF ↗ |
| 06 Jan 2026 | Hypurin® Porcine 30/70 Mix (insulin isophane biphasic porcine) 100units/ml | MSAN(2026)2 | Level 2 | mid-January | PDF ↗ |
| 06 Jan 2026 | Diamorphine 5mg, 10mg and 100mg powder for solution for injection ampoules | MSAN(2026)1 | Level 3 | — | PDF ↗ |
| 30 Dec 2025 | Pen device for Genotropin® (somatropin) 5.3 mg and 12 mg powder and solvent | MSAN(2025)58 | Level 2 | early 2027 | PDF ↗ |
| 30 Dec 2025 | Clonidine (Catapres®) 100microgram tablets | MSAN(2025)57 | Level 2 | mid-February 2026 | PDF ↗ |
| 24 Dec 2025 | Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) eye drops 0.2ml | MSAN(2025)56 | Level 2 | early February 2026 | PDF ↗ |
| 24 Dec 2025 | Nifedipine (Adipine® XL) 30mg and 60mg modified-release tablets | MSAN(2025)55 | Level 2 | end of January 2026 | PDF ↗ |
| 16 Dec 2025 | Tresiba® FlexTouch® (insulin degludec) 100units/ml solution for injection 3ml | MSAN(2025)54 | Level 2 | product has been discontinued | PDF ↗ |
| 16 Dec 2025 | Fiasp® FlexTouch® (insulin aspart) 100units/ml solution for injection 3ml pre- ⚠ | MSAN(2024)53 | Level 2 | product has been discontinued | PDF ↗ |
| 12 Dec 2025 | Nifedipine (Fortipine® LA) 40mg modified-release tablets | MSAN(2025)52 | Level 2 | TBC - Please refer to medicines supply tool on the Specialist | PDF ↗ |
| 09 Dec 2025 | Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches | MSAN(2025)51 | Level 3 | w/c 22 December 2025 | PDF ↗ |
| 19 Nov 2025 | Ibandronic acid 150mg tablets | MSAN(2025)50 | Level 2 | March 2026 | PDF ↗ |
| 13 Nov 2025 | Propranolol 80mg and 160mg modified release capsules | MSAN(2025)49 | Level 2 | early March 2026 | PDF ↗ |
| 27 Oct 2025 | Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for | MSAN(2025)48 | Level 2 | noted product have been discontinued | PDF ↗ |
| 27 Oct 2025 | Mometasone (Asmanex Twisthaler®) 200micrograms/dose dry powder and | MSAN(2025)47 | Level 2 | above noted products are being discontinued | PDF ↗ |
| 27 Oct 2025 | Dalivit® Oral Drops | MSAN(2025)46 | Level 2 | TBC - Please refer to medicines supply tool on the Specialist | PDF ↗ |
| 27 Oct 2025 | Amiodarone 100mg and 200mg tablets | MSAN(2025)45 | Level 2 | w/c 17 November 2025 | PDF ↗ |
| 27 Oct 2025 | Antimicrobial Agents Used in Tuberculosis (TB) Treatment | MSAN(2025)44 | Level 3 | TBC - Please refer to medicines supply tool on the Specialist | PDF ↗ |
| 22 Sep 2025 | Admelog® (insulin lispro) 100units/ml solution for injection 3ml cartridges | MSAN(2025)43 | Level 2 | June 2026 | PDF ↗ |
| 28 Aug 2025 | Repaglinide 500microgram,1mg and 2mg tablets | MSAN(2025)42 | Level 2 | early December 2025 | PDF ↗ |
| 25 Aug 2025 | Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml | MSAN(2025)41 | Level 2 | noted products are being discontinued | PDF ↗ |
| 19 Aug 2025 | Estradiol (Progynova® TS) 50micrograms/24hours and 100micrograms/24hours | MSAN(2025)40 | Level 2 | above noted product is being discontinued | PDF ↗ |
| 28 Jul 2025 | Isosorbide mononitrate 10mg tablets (immediate-release) | MSAN(2025)39 | Level 2 | early September 2025 | PDF ↗ |
| 28 Jul 2025 | • Hypurin® Porcine Isophane (insulin isophane porcine) 100units/ml | MSAN(2025)38 | Level 2 | above noted products are being discontinued | PDF ↗ |
| 28 Jul 2025 | • Humulin® I (insulin isophane human) 100units/ml suspension for injection | MSAN(2025)37 | Level 2 | above noted products are being discontinued | PDF ↗ |
| 18 Jul 2025 | Abidec® Multivitamin drops | MSAN(2025)36 | Level 2 | TBC, further updates on the anticipated resupply date for this | PDF ↗ |
| 18 Jul 2025 | Amiodarone 200mg tablets | MSAN(2025)35 | Level 2 | early August 2025 | PDF ↗ |
| 11 Jul 2025 | Diclofenac (Voltarol® Ophtha) 0.1% eye drops 0.3ml unit dose preservative free | MSAN(2025)34 | Level 2 | early October 2025 | PDF ↗ |
| 11 Jul 2025 | Salbutamol 100micrograms/dose breath actuated inhalers CFC free | MSAN(2025)33 | Level 2 | December 2025 | PDF ↗ |
| 08 Jul 2025 | Betamethasone 500microgram soluble tablets sugar free | MSAN(2025)32 | Level 2 | mid-October 2025 | PDF ↗ |
| 25 Jun 2025 | Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour, | MSAN(2025)31 | Level 2 | early October 2025 | PDF ↗ |
| 18 Jun 2025 | Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml | MSAN(2025)30 | Level 2 | noted products are being discontinued | PDF ↗ |
| 18 Jun 2025 | Insulatard® (isophane insulin, human) Penfill® 100units/ml suspension for | MSAN(2025)29 | Level 2 | noted product is being discontinued | PDF ↗ |
| 18 Jun 2025 | Venlafaxine 37.5mg modified release tablets | MSAN(2025)28 | Level 2 | mid-July 2025 | PDF ↗ |
| 06 Jun 2025 | NovoRapid® PumpCart® (insulin aspart) 100units/ml solution for injection 1.6ml | MSAN(2025)27 | Level 2 | early 2027 | PDF ↗ |
| 27 May 2025 | Phenobarbital 15mg/5ml elixir | MSAN(2025)26 | Level 2 | late June 2025 | PDF ↗ |
| 27 May 2025 | Tolterodine 2mg and 4mg modified-release capsules | MSAN(2025)25 | Level 2 | mid-September 2025 | PDF ↗ |
| 16 May 2025 | Buprenorphine (Reletrans®) 5micrograms/hour and 15micrograms/hour | MSAN(2025)24 | Level 2 | early July 2025 | PDF ↗ |
| 16 May 2025 | Lidocaine (Xylocaine®) 10mg/dose spray sugar free | MSAN(2025)23 | Level 2 | 30 June 2025 | PDF ↗ |
| 07 May 2025 | Tuberculosis (TB) oral medicines | MSAN(2025)22 | Level 2 | various resupply dates – see below | PDF ↗ |
| 07 May 2025 | Diazepam 10mg/2ml solution for injection ampoules | MSAN(2025)21 | Level 2 | October 2025 | PDF ↗ |
| 07 May 2025 | Fentanyl (Effentora®) 200microgram, 400microgram, 600microgram, | MSAN(2025)20 | Level 2 | various resupply dates – please see information below | PDF ↗ |
| 22 Apr 2025 | Levofloxacin 250mg and 500mg tablets | MSAN(2025)19 | Level 2 | late May 2025 | PDF ↗ |
| 22 Apr 2025 | Fentanyl (Durogesic® DTrans®) 12 micrograms/hour, 25 micrograms/hour, | MSAN(2025)18 | Level 2 | December 2025 | PDF ↗ |
| 22 Apr 2025 | Galantamine 8mg, 16mg and 24mg modified-release capsules | MSAN(2025)17 | Level 2 | July 2025 | PDF ↗ |
| 11 Apr 2025 | Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml | MSAN(2025)16 | Level 2 | noted products are being discontinued | PDF ↗ |
| 11 Apr 2025 | Diltiazem (Angitil® SR) 90 mg modified-release capsules | MSAN(2025)15 | Level 2 | w/c 28 April 2025 | PDF ↗ |
| 11 Apr 2025 | Estradiol (Estradot®) 25 micrograms/24 hours, 37.5 micrograms/24 hours, 50 | MSAN(2025)14 | Level 2 | various resupply dates – see below | PDF ↗ |
| 26 Mar 2025 | Salbutamol (Salamol Easi-Breathe®) 100micrograms/dose breath actuated | MSAN(2025)11 | Level 2 | early April 2025 | PDF ↗ |
| 26 Mar 2025 | Desmopressin 10microgram/dose nasal spray | MSAN(2025)10 | Level 2 | early September 2025 | PDF ↗ |
| 04 Mar 2025 | Triptorelin acetate (Gonapeptyl® Depot) 3.75mg powder and solvent for | MSAN(2025)9 | Level 2 | early January 2026 | PDF ↗ |
| 14 Feb 2025 | Quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets | MSAN(2025)8 | Level 2 | Various dates, please refer to the summary supply table below | PDF ↗ |
| 05 Feb 2025 | Camellia sinensis extract (Catephen®) 10% ointment | MSAN(2025)7 | Level 2 | late April 2025 | PDF ↗ |
| 05 Feb 2025 | Memantine (Valios®) 5mg orodispersible tablets sugar free | MSAN(2025)6 | Level 2 | late April 2025 | PDF ↗ |
| 22 Jan 2025 | 22 January 2025 | MSAN(2025)5 | — | — | PDF ↗ |
| 16 Jan 2025 | Zanamivir (Dectova®) 200mg/20ml solution for infusion vials | MSAN(2025)3 | Level 3 | late January 2025 | PDF ↗ |
| 11 Jan 2025 | Apomorphine hydrochloride (APO-go® PFS) 50mg/10ml solution for infusion | MSAN(2025)2 | Level 2 | product is being discontinued | PDF ↗ |
| 11 Jan 2025 | NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml | MSAN(2025)1 | Level 2 | product is being discontinued | PDF ↗ |
| 27 Dec 2024 | Prednisolone 20mg/100ml rectal solution | MSAN(2024)70 | Level 2 | February 2025 | PDF ↗ |
| 27 Dec 2024 | Estradiol (Estradot®) 50micrograms/24 hours, 75micrograms/24 hours, and | MSAN(2024)69 | Level 2 | various resupply dates – see below | PDF ↗ |
| 27 Dec 2024 | Isosorbide mononitrate 10mg, 20mg and 40mg tablets (immediate-release) | MSAN(2024)68 | Level 2 | late February 2025 | PDF ↗ |
| 27 Dec 2024 | Cefalexin 125mg/5ml and 250mg/5ml oral suspensions, sugar free | MSAN(2024)67 | Level 2 | mid-2025 | PDF ↗ |
| 11 Dec 2024 | Imiquimod (Aldara® 5% and Bascellex® 50mg/g) cream 250mg sachets | MSAN(2024)66 | Level 2 | mid-January 2025 | PDF ↗ |
| 11 Dec 2024 | Diclofenac (Voltarol® Ophtha Multidose) 0.1% eye drops | MSAN(2024)65 | Level 2 | mid-March 2025 | PDF ↗ |
| 11 Dec 2024 | Coal tar extract (Neutrogena® T/Gel® Therapeutic) 2% shampoo | MSAN(2024)64 | Level 2 | product is being discontinued from February 2025. | PDF ↗ |
| 22 Nov 2024 | NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml | MSAN(2024)63 | Level 2 | product is being discontinued | PDF ↗ |
| 21 Nov 2024 | Levobunolol (Betagan®) 0.5% eye drops 0.4ml unit dose preservative free | MSAN(2024)62 | Level 2 | product is being discontinued | PDF ↗ |
| 30 Oct 2024 | Rifampicin and Isoniazid (Rifinah®) 300mg/150mg tablets | MSAN(2024)61 | Level 2 | mid-November 2024 | PDF ↗ |
| 16 Oct 2024 | Trandate® (labetalol) 50mg tablets | MSAN(2024)60 | Level 2 | product to be discontinued from July 2025 | PDF ↗ |
| 16 Oct 2024 | Artemether 20mg / lumefantrine 120mg (Riamet®) tablets | MSAN(2024)59 | Level 2 | mid-November 2024 | PDF ↗ |
| 16 Oct 2024 | Torasemide 10mg tablets | MSAN(2024)58 | Level 2 | March 2025 | PDF ↗ |
| 04 Oct 2024 | Isosorbide mononitrate 60mg modified-release tablets and capsules - Update | MSAN(2024)57 | Level 2 | various re-supply dates, see below | PDF ↗ |
| 24 Sep 2024 | Lanreotide 60mg/0.5ml, 90mg/0.5ml and 120mg/0.5ml solution for injection pre- | MSAN(2024)56 | Level 2 | end of November 2024 | PDF ↗ |
| 24 Sep 2024 | Nicorandil 10mg tablets | MSAN(2024)55 | Level 2 | 4th October 2024 | PDF ↗ |
| 20 Sep 2024 | Trandolapril 2mg and 4mg capsules | MSAN(2024)54 | Level 2 | Late December 2024 | PDF ↗ |
| 30 Aug 2024 | Naloxone (Nyxoid®) 1.8mg/0.1ml nasal spray unit dose | MSAN(2024)53 | Level 2 | w/c 30th September 2024 | PDF ↗ |
| 28 Aug 2024 | Isosorbide mononitrate 60mg modified-release tablets and capsules | MSAN(2024)52 | Level 2 | various re-supply dates, see below | PDF ↗ |
| 28 Aug 2024 | Creon® Micro Pancreatin 60.12mg gastro-resistant granules | MSAN(2024)51 | Level 3 | late September 2024 | PDF ↗ |
| 28 Aug 2024 | Norethisterone (Noriday®) 350microgram tablets | MSAN(2024)50 | Level 2 | early December 2024 | PDF ↗ |
| 28 Aug 2024 | Naltrexone 50mg tablets | MSAN(2024)49 | Level 2 | late October 2024 | PDF ↗ |
| 23 Aug 2024 | Methylphenidate prolonged-release tablets | MSAN(2024)48 | Level 3 | October 2024 | PDF ↗ |
| 09 Aug 2024 | Cefalexin 500mg tablets | MSAN(2024)47 | Level 2 | late September 2024 | PDF ↗ |
| 09 Aug 2024 | Ramipril 2.5mg tablets | MSAN(2024)46 | Level 2 | November 2024 | PDF ↗ |
| 05 Aug 2024 | Desmopressin (DDAVP®) 4 micrograms/1ml solution for injection ampoules | MSAN(2024)45 | Level 2 | w/c 16th September | PDF ↗ |
| 24 Jul 2024 | Quetiapine 150mg, 200mg, 300mg tablets - UPDATE | MSAN(2024)43 | Level 2 | late August 2024 | PDF ↗ |
| 17 Jul 2024 | Ipratropium bromide 250micrograms/1ml and 500micrograms/2ml nebuliser | MSAN(2024)42 | Level 2 | late March 2025 | PDF ↗ |
| 05 Jul 2024 | Disopyramide (Rythmodan Retard®) 250mg modified-release tablets and | MSAN(2024)41 | Level 2 | mid-January 2025 | PDF ↗ |
| 28 Jun 2024 | Disopyramide (Rythmodan Retard®) 250mg modified-release tablets and | MSAN(2024)40 | Level 2 | mid-January 2025 | PDF ↗ |
| 11 Jun 2024 | Quetiapine 150mg, 200mg, 300mg tablets | MSAN(2024)35 | Level 2 | late August 2024 | PDF ↗ |
| 11 Jun 2024 | Imiquimod (Aldara®) 5% cream and podophyllotoxin (Warticon®) 0.5% solution | MSAN(2024)34 | Level 2 | mid-October 2024 | PDF ↗ |
| 11 Jun 2024 | Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free | MSAN(2024)33 | Level 2 | early September 2024 | PDF ↗ |
| 11 Jun 2024 | Clomethiazole 192mg capsules | MSAN(2024)32 | Level 2 | mid-July 2024 | PDF ↗ |
| 30 May 2024 | Somatropin (NutropinAq®) 10mg/2ml solution for injection cartridges | MSAN(2024)31 | Level 2 | Products have been discontinued | PDF ↗ |
| 30 May 2024 | Memantine (Valios®) 10mg and 20mg orodispersible tablets sugar free | MSAN(2024)30 | Level 2 | late August 2024 | PDF ↗ |
| 30 May 2024 | Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials | MSAN(2024)29 | Level 2 | TBC | PDF ↗ |
| 30 May 2024 | Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions | MSAN(2024)28 | Level 2 | TBC | PDF ↗ |
| 30 May 2024 | Nortriptyline 10mg/5ml and 25mg/5ml oral solution sugar-free | MSAN(2024)27 | Level 2 | Products are being discontinued | PDF ↗ |
| 20 May 2024 | Humulin® S (insulin soluble human) 100units/ml solution for injection 10ml | MSAN(2024)26 | Level 2 | mid-June 2024 | PDF ↗ |
| 17 May 2024 | Tegretol® (carbamazepine) 100mg/5ml liquid | MSAN(2024)25 | Level 2 | TBC | PDF ↗ |
| 13 May 2024 | Pancreatic enzyme replacement therapy (PERT) | MSAN(2024)24 | Level 2 | Various resupply dates, please see below | PDF ↗ |
| 13 May 2024 | Humalog® (insulin lispro) 100units/ml solution for injection 10ml vials | MSAN(2024)23 | Level 2 | late May 2024 | PDF ↗ |
| 27 Apr 2024 | Mesalazine (Asacol®) 400mg MR gastro-resistant tablets | MSAN(2024)18 | Level 2 | discontinued - stock to be exhausted by late April 2024 | PDF ↗ |
| 25 Apr 2024 | Naloxegol (Moventig®) 12.5mg and 25mg tablets | MSAN(2024)17 | Level 2 | early August 2024 | PDF ↗ |
| 25 Apr 2024 | Carbamazepine 100mg and 200mg tablets | MSAN(2024)16 | Level 2 | mid-June 2024 | PDF ↗ |
| 25 Apr 2024 | Phenobarbital 15mg tablets (Accord) | MSAN(2024)15 | Level 2 | TBC | PDF ↗ |
| 28 Mar 2024 | Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for | MSAN(2024)10 | Level 2 | being discontinued, stock exhausted by the end of May 2024 | PDF ↗ |
| 19 Mar 2024 | Semaglutide (Ozempic®) 0.25mg, 0.5mg and 1mg solution for injection in a pre- | MSAN(2024)9 | Level 3 | end of 2024 | PDF ↗ |
| 15 Mar 2024 | Jext® 300micrograms/0.3ml (adrenaline 1 in 1000) solution for injection auto- | MSAN(2024)8 | Level 2 | w/c 25 March 2024 | PDF ↗ |
| 08 Mar 2024 | Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials - Update | MSAN(2024)7 | Level 2 | late June 2024 | PDF ↗ |
| 06 Mar 2024 | Lisdexamfetamine (Elvanse®) capsules | MSAN(2024)6 | Level 2 | April 2024 | PDF ↗ |
| 06 Mar 2024 | Fiasp® FlexTouch® (insulin aspart) 100units/ml solution for injection 3ml pre- | MSAN(2024)5 | Level 2 | January 2025 | PDF ↗ |
| 29 Feb 2024 | Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials | MSAN(2024)4 | Level 3 | TBC | PDF ↗ |
| 29 Feb 2024 | Midazolam (Epistatus®) 5mg/0.5ml oromucosal solution pre-filled oral syringes | MSAN(2024)3 | Level 2 | TBC | PDF ↗ |
| 29 Feb 2024 | Epilim® (sodium valproate) syrup 200mg/5ml | MSAN(2024)2 | Level 2 | w/c 22nd April 2024 | PDF ↗ |
| 12 Feb 2024 | Methadone 5mg tablets | MSAN(2024)1 | Level 2 | late May 2024 | PDF ↗ |
| 16 Oct 2023 | Azithromycin (Azyter®) 15mg/g eye drops (0.25g unit dose, preservative free) | MSAN(2023)35 | Level 2 | mid-November 2023 | PDF ↗ |
| 16 Oct 2023 | Pancrease® HL gastro-resistant capsules | MSAN(2023)34 | Level 2 | discontinuation, stock to be exhausted by mid-November 2023 | PDF ↗ |
| 16 Oct 2023 | Bumetanide 1mg and 5mg tablets | MSAN(2023)33 | Level 3 | March 2024 | PDF ↗ |
| 06 Oct 2023 | Progesterone (Lutigest® ) 100mg vaginal tablets | MSAN(2023)32 | Level 2 | late December 2023 | PDF ↗ |
| 06 Oct 2023 | Hyoscine hydrobromide (Scopoderm®) 1.5mg patches | MSAN(2023)31 | Level 2 | until w/c 1st January 2024 | PDF ↗ |
| 04 Oct 2023 | Disopyramide (Rythmodan®)100mg capsules | MSAN(2023)30 | Level 2 | late October 2023 | PDF ↗ |
| 03 Oct 2023 | Azelaic acid (Skinoren®) 20% cream | MSAN(2023)29 | Level 2 | early November 2023 | PDF ↗ |
| 29 Sep 2023 | Somatropin (Genotropin® MiniQuick) 1.4mg powder and solvent for solution for | MSAN(2023)28 | Level 2 | w/c 1st January 2024 | PDF ↗ |
| 29 Sep 2023 | Midazolam (Epistatus®) 2.5mg/0.25mL and 10mg/1mL oromucosal solution pre- | MSAN(2023)27 | Level 2 | late November 2023 | PDF ↗ |
| 29 Sep 2023 | Discontinuation of lixisenatide (Lyxumia®) 20micrograms/0.2ml solution for | MSAN(2023)26 | Level 2 | stock will be exhausted by w/c 18th December 2023 | PDF ↗ |
| 19 Sep 2023 | Estradiol (FemSeven®) 75micrograms/24hours and 100micrograms/24hours | MSAN(2023)25 | Level 2 | w/c 2nd October 2023 | PDF ↗ |
| 19 Sep 2023 | Estradiol valerate/medroxyprogesterone acetate (Indivina®) 1mg/5mg tablets | MSAN(2023)24 | Level 2 | w/c 11th December 2023 | PDF ↗ |
| 15 Sep 2023 | Permethrin 5% w/w cream | MSAN(2023)23 | Level 2 | further notice | PDF ↗ |
| 29 Aug 2023 | Jext® 300 micrograms/0.3mL (1 in 1000) solution for injection auto-injector pen | MSAN(2023)22 | Level 2 | w/c 11th September 2023 | PDF ↗ |
| 29 Aug 2023 | Phenytoin sodium 100mg capsules (Accord) | MSAN(2023)21 | Level 3 | late December 2023 | PDF ↗ |
| 29 Aug 2023 | Pilocarpine hydrochloride 2% eye drops | MSAN(2023)20 | Level 2 | late September 2023 | PDF ↗ |
| 29 Aug 2023 | Minims® Povidone Iodine 5% w/v Eye Drops, Solution | MSAN(2023)19 | Level 3 | early October 2023 | PDF ↗ |
| 29 Aug 2023 | Minims® Oxybuprocaine hydrochloride 0.4% eye drops 0.5ml unit dose | MSAN(2023)18 | Level 3 | early October 2023 | PDF ↗ |
| 29 Aug 2023 | Estradiol (Estradot®) 25micrograms/24 hours, 37.5micrograms/24 hours and | MSAN(2023)17 | Level 2 | late September 2023 | PDF ↗ |
| 22 Aug 2023 | Disulfiram 200mg tablets | MSAN(2023)16 | Level 2 | late August 2023 | PDF ↗ |
| 07 Aug 2023 | Tegretol® (carbamazepine) 100mg tablets | MSAN(2023)15 | Level 2 | end August 2023 | PDF ↗ |
| 07 Aug 2023 | Edronax® (reboxetine) 4mg tablets | MSAN(2023)14 | Level 2 | end of October 2023 | PDF ↗ |
| 25 Jul 2023 | Atomoxetine 40mg and 60mg capsules | MSAN(2023)13 | Level 2 | September 2023 | PDF ↗ |
| 12 Jul 2023 | GLP-1 receptor agonists used in the management of type 2 diabetes | MSAN(2023)12 | Level 3 | mid-2024 | PDF ↗ |
| 09 Jun 2023 | Norditropin® Flexpro® and NordiFlex® (somatropin) solution for injection pre- | MSAN(2023)11 | Level 2 | September 2023 | PDF ↗ |
| 09 Jun 2023 | Micronised Progesterone (Utrogestan®) 100mg capsules | MSAN(2023)10 | Level 2 | end of 2023 | PDF ↗ |
| 09 Jun 2023 | Tresiba (insulin degludec) FlexTouch 100units/ml solution for injection 3ml pre-filled | MSAN(2023)9 | Level 2 | January 2024 | PDF ↗ |
| 09 Jun 2023 | Glucagon 1mg powder for injection kit (GlucaGen®) | MSAN(2023)8 | Level 2 | mid- July 2023 | PDF ↗ |
| 09 Jun 2023 | Ethinylestradiol 20microgram / Drospirenone 3mg (Eloine®) tablets | MSAN(2023)7 | Level 2 | late August 2023 | PDF ↗ |
| 09 Jun 2023 | Bromfenac (Yellox®) 900 micrograms/ml eye drops | MSAN(2023)6 | Level 2 | w/c 3 July 2023 | PDF ↗ |
| 25 Jan 2023 | • Insulin isophane biphasic human 25/75 (Insuman® Comb 25) 100units/ml | MSAN(2023)4 | Level 2 | discontinuation, stock to be exhausted by May 2023 | PDF ↗ |
| 24 Jan 2023 | Vigabatrin (Sabril®) 500mg tablets | MSAN(2023)5 | Level 2 | w/c 3rd of March 2023 | PDF ↗ |
| 16 Jan 2023 | Sulfasalazine 250mg in 5ml oral suspension sugar free | MSAN(2023)3 | Level 2 | until early June 2023 | PDF ↗ |
| 16 Jan 2023 | Dalteparin (Fragmin®) 10,000units/1mL solution for injection ampoule | MSAN(2023)2 | Level 3 | discontinuation - stock to be exhausted by May 2023 | PDF ↗ |
| 16 Jan 2023 | Selegiline (Eldepryl®) 5mg and 10mg tablets | MSAN(2023)1 | Level 2 | until April 2023 | PDF ↗ |
| 30 Dec 2022 | Antibiotics for the treatment of Group A Strep - Update | MSAN(2022)7 | Level 3 | TBC | PDF ↗ |
| 14 Dec 2022 | Antibiotics for the treatment of Group A Strep | MSAN(2022)6 | Level 2 | TBC | PDF ↗ |
| 04 Nov 2022 | NovoRapid FlexPen® (Insulin aspart) 100units/ml solution for injection 3ml pre- | MSAN(2022)5 | Level 3 | 21 November 2022 | PDF ↗ |
| 29 Jul 2022 | Promethazine hydrochloride 25mg tablets | MSAN(2022)4 | Level 2 | until Mid-August 2022 | PDF ↗ |
| 29 Jul 2022 | Hydrocortisone 2.5mg Muco-Adhesive Buccal Tablets | MSAN(2022)3 | Level 2 | w/c 5th September 2022 | PDF ↗ |
| 19 Jul 2022 | Alendronic acid 70mg tablets | MSAN(2022)2 | Level 2 | late-August 2022. | PDF ↗ |
| 19 Jul 2022 | Paroxetine (Seroxat®) 20mg/10ml oral suspension | MSAN(2022)1 | Level 2 | to be discontinued in July 2022 | PDF ↗ |
| 09 Nov 2021 | Tocilizumab (RoActemra®) 162mg/0.9ml solution for injection pre-filled | MSAN(2021)34 | Level 3 | January 2022 | PDF ↗ |
| 09 Nov 2021 | Champix® (varenicline) 0.5mg and 1mg tablets | MSAN(2021)33 | Level 3 | further notice | PDF ↗ |
| 08 Nov 2021 | Latanoprost 50microgram/ml / timolol 5mg/ml (Fixapost®) 0.2ml unit dose | MSAN(2021)32 | Level 2 | Mid November 2021 | PDF ↗ |
| 08 Nov 2021 | Acebutolol (Sectral®) 100mg capsules | MSAN(2021)31 | Level 2 | discontinued, stock expected to be exhausted by the end of | PDF ↗ |
| 06 Aug 2021 | Dalacin® (clindamycin) 2% vaginal cream | MSAN(2021)30 | Level 2 | w/c 6th September 2021 | PDF ↗ |
| 06 Aug 2021 | Kolanticon gel® (2.5mg dicycloverine hydrochloride, 200mg aluminium | MSAN(2021)29 | Level 2 | January 2022 | PDF ↗ |
| 06 Aug 2021 | Tuberculosis (TB) oral agents ⚠ | MSAN(2021)28 | Level 2 | See table | PDF ↗ |
| 06 Aug 2021 | Tinzaparin sodium (10,000 IU/ml) 3,500 units in 0.35 ml and 4,500 units in 0.45 ⚠ | MSAN(2021)27 | Level 3 | January 2022 | PDF ↗ |
| 06 Aug 2021 | Glipizide (Minodiab®) 5mg tablets | MSAN(2021)26 | Level 3 | mid-October 2021 | PDF ↗ |
| 03 Aug 2021 | Clexane® (enoxaparin) pre-filled syringes | MSAN(2021)25 | Level 2 | November 2021 | PDF ↗ |
| 03 Aug 2021 | Nexium® (esomeprazole) 10mg gastro-resistant granules sachets | MSAN(2021)24 | Level 2 | w/c 16th August 2021 | PDF ↗ |
| 03 Aug 2021 | Catapres® (clonidine) 100microgram tablets | MSAN(2021)23 | Level 2 | w/c 4th October 2021 | PDF ↗ |
| 03 Aug 2021 | Locorten Vioform® (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear drops | MSAN(2021)22 | Level 2 | April 2022 | PDF ↗ |
| 03 Aug 2021 | Gentisone HC® (Gentamicin 0.3% w/v and Hydrocortisone acetate 1% w/v) Ear | MSAN(2021)21 | Level 2 | w/c 25th October 2021 | PDF ↗ |
| 22 Apr 2021 | Pioglitazone 15mg/metformin 850mg (Competact®) tablets | MSAN(2021)20 | Level 2 | early May 2021 | PDF ↗ |
| 15 Apr 2021 | Chloral Hydrate 143.3mg in 5ml oral solution | MSAN(2021)19 | Level 2 | September 2021 | PDF ↗ |
| 15 Apr 2021 | Diamorphine hydrochloride powder for reconstitution and injection 5mg and ⚠ | MSAN(2021)18 | Level 2 | w/c 19th April 2021 | PDF ↗ |
| 15 Apr 2021 | Voriconazole (VFEND®) 40mg/ml powder for oral suspension | MSAN(2021)17 | Level 2 | late April 2021 | PDF ↗ |
| 15 Apr 2021 | Rifinah® 300mg/150mg (rifampicin 300mg/isoniazid 150mg) tablets | MSAN(2021)16 | Level 2 | late April 2021 | PDF ↗ |
| 31 Mar 2021 | H2-antagonists (cimetidine, famotidine and nizatidine) | MSAN(2021)15 | Level 2 | various dates | PDF ↗ |
| 31 Mar 2021 | Oral Contraceptive tablets (various brands) | MSAN(2021)14 | Level 2 | Various dates - see table | PDF ↗ |
| 23 Mar 2021 | Irbesartan/hydrochlorothiazide 150mg/12.5mg tablets | MSAN(2021)13 | Level 2 | early May 2021 | PDF ↗ |
| 23 Mar 2021 | Enalapril 5mg tablets | MSAN(2021)12 | Level 2 | end of April 2021 | PDF ↗ |
| 16 Mar 2021 | Repaglinide 1mg and 2mg tablets | MSAN(2021)11 | Level 3 | early May 2021 | PDF ↗ |
| 08 Mar 2021 | Desmopressin (Octim®) 150 micrograms per actuation nasal spray (Ferring | MSAN(2021)10 | Level 2 | Q3 of 2023 - update to MSAN(2020)95 | PDF ↗ |
| 08 Mar 2021 | Sancuso® (granisetron) 3.1mg/24 hours transdermal | MSAN(2021)7 | Level 2 | until late March 2021 | PDF ↗ |
| 08 Mar 2021 | Colestid® (colestipol) orange and plain 5g granules sachets | MSAN(2021)6 | Level 2 | end of May 2021 | PDF ↗ |
| 05 Mar 2021 | Morphine sulphate (MST CONTINUS®) 20mg, 30mg, 60mg, 100mg and 200mg | MSAN(2021)5 | Level 3 | being discontinued | PDF ↗ |
| 02 Mar 2021 | Midazolam 10mg/2ml solution for injection ampoules ⚠ | MSAN(2021)4 | Level 2 | until April 2021 | PDF ↗ |
| 02 Mar 2021 | Acetazolamide SR 250mg capsules | MSAN(2021)3 | Level 2 | until May 2021 | PDF ↗ |
| 02 Mar 2021 | Fluoxetine 40mg capsules | MSAN(2021)2 | Level 2 | end of March 2021 | PDF ↗ |
| 23 Feb 2021 | Phyllocontin® (Aminophylline) 225mg and 350mg modified release tablets | MSAN(2021)1 | Level 3 | being discontinued, supplies are to be exhausted by 5th April 2021 | PDF ↗ |
| 29 Dec 2020 | Docusate sodium 100mg capsules | MSAN(2020)119 | Level 2 | April 2021 | PDF ↗ |
| 29 Dec 2020 | Butec® (buprenorphine) 15microgram/hour transdermal patches (7-day) | MSAN(2020)118 | Level 2 | w/c 18 January 2021 | PDF ↗ |
| 29 Dec 2020 | Dulcolax® (bisacodyl) 5mg and 10mg suppositories | MSAN(2020)117 | Level 2 | various, see table below | PDF ↗ |
| 29 Dec 2020 | Rifadin® (rifampicin) 100mg/5ml oral suspension | MSAN(2020)116 | Level 2 | w/c 18 January 2021 | PDF ↗ |
| 29 Dec 2020 | Zemtard® (diltiazem) 240mg XL capsules | MSAN(2020)115 | Level 2 | w/c 1 February 2021 | PDF ↗ |
| 29 Dec 2020 | Phytomenadione (Konakion MM Paediatric) 2mg/0.2ml ampoules | MSAN(2020)114 | Level 2 | until late January 2021 | PDF ↗ |
| 17 Nov 2020 | Nalcrom® (sodium cromoglicate) 100mg capsules | MSAN(2020)113 | Level 2 | early January 2021 | PDF ↗ |
| 17 Nov 2020 | Trifluoperazine 1mg/5ml syrup (Advanz Pharma) | MSAN(2020)112 | Level 2 | April 2021 | PDF ↗ |
| 17 Nov 2020 | Dulcolax® (bisacodyl) 5mg and 10mg suppositories | MSAN(2020)111 | Level 2 | various, see table below | PDF ↗ |
| 09 Nov 2020 | Haloperidol 5mg/5ml oral solution sugar free (Thame Laboratories) | MSAN(2020)110 | Level 2 | March 2021 | PDF ↗ |
| 09 Nov 2020 | Nalcrom® (sodium cromoglicate) 100mg capsules | MSAN(2020)109 | Level 2 | late November 2020 | PDF ↗ |
| 09 Nov 2020 | H2-antagonists (cimetidine, famotidine and nizatidine) | MSAN(2020)108 | Level 2 | Various dates | PDF ↗ |
| 09 Nov 2020 | Zonisamide capsules various strengths (Glenmark and Teva) ⚠ | MSAN(2020)107 | Level 2 | mid-February 2021 | PDF ↗ |
| 09 Nov 2020 | Prednisolone 5mg Suppositories (RPH Pharmaceuticals) | MSAN(2020)106 | Level 2 | January 2021 | PDF ↗ |
| 23 Oct 2020 | Salazopyrin En-Tabs® (sulfasalazine) 500mg tablets | MSAN(2020)105 | Level 1 | early December 2020 | PDF ↗ |
| 23 Oct 2020 | Fluoxetine 30mg capsules (Advanz) | MSAN(2020)104 | Level 2 | mid-December 2020 | PDF ↗ |
| 23 Oct 2020 | Ferrous Fumarate 322mg/Folic Acid 350microgram (Pregaday®) tablets | MSAN(2020)103 | Level 2 | late November 2020 | PDF ↗ |
| 21 Oct 2020 | Dulcolax® (bisacodyl) 5mg suppositories | MSAN(2020)102 | Level 2 | early December 2020 | PDF ↗ |
| 21 Oct 2020 | DDAVP® (Desmopressin) 0.01% w/v (100 micrograms/ml) intranasal solution | MSAN(2020)101 | Level 2 | mid-2021 | PDF ↗ |
| 15 Oct 2020 | Lithium carbonate (Priadel®) 200mg and 400mg modified release tablets | MSAN(2020)100 | Level 3 | further notice | PDF ↗ |
| 09 Oct 2020 | Sterculia (Normacol®) 62% w/w granules | MSAN(2020)99 | Level 2 | late October 2020 | PDF ↗ |
| 09 Oct 2020 | Oral Contraceptive tablets (various brands) | MSAN(2020)98 | Level 2 | Various – see table | PDF ↗ |
| 09 Oct 2020 | H2-antagonists (cimetidine, famotidine and nizatidine) | MSAN(2020)97 | Level 2 | Various dates | PDF ↗ |
| 09 Oct 2020 | Lorazepam (Ativan®) 4mg/ml Solution for injection (Pfizer) | MSAN(2020)96 | Level 2 | Early December 2020 | PDF ↗ |
| 09 Oct 2020 | Desmopressin (Octim®) 150 micrograms per actuation nasal spray (Ferring | MSAN(2020)95 | Level 2 | mid-2021 | PDF ↗ |
| 29 Sep 2020 | Tuberculosis (TB) oral agents ⚠ | MSAN(2020)94 | Level 2 | Various - please see table below | PDF ↗ |
| 29 Sep 2020 | Sterculia (Normacol®) 62% w/w granules | MSAN(2020)93 | Level 2 | Early October 2020 | PDF ↗ |
| 29 Sep 2020 | Enalapril 20mg tablets (various suppliers) | MSAN(2020)92 | Level 2 | Mid-end October 2020 | PDF ↗ |
| 29 Sep 2020 | Metronidazole (Acea®) 0.75% gel (Ferndale Pharmaceuticals) | MSAN(2020)91 | Level 2 | January 2021 | PDF ↗ |
| 29 Sep 2020 | Fluticasone propionate (Flixotide®) 0.5mg/2ml and 2mg/2ml Nebules | MSAN(2020)90 | Level 2 | Mid-February 2021 | PDF ↗ |
| 29 Sep 2020 | Zonisamide 50mg and 100mg Capsules (Teva) | MSAN(2020)89 | Level 2 | Late November 2020 | PDF ↗ |
| 03 Sep 2020 | Lithium carbonate (Priadel®) 200mg and 400mg modified release tablets | MSAN(2020)88 | Level 3 | To be discontinued, supplies are expected to be exhausted by April | PDF ↗ |
| 28 Aug 2020 | Sterculia (Normacol®) 62% w/w granules | MSAN(2020)87 | Level 2 | 13 September | PDF ↗ |
| 27 Aug 2020 | Esomeprazole 40mg iv powder for solution (Grunenthal, Ranbaxy, Tillomed) | MSAN(2020)86 | Level 2 | Early 2021 | PDF ↗ |
| 26 Aug 2020 | Lodoxamide 0.1% (Alomide®) eye drops | MSAN(2020)85 | Level 2 | TBC | PDF ↗ |
| 26 Aug 2020 | Nabumetone 500mg Tablets | MSAN(2020)84 | Level 2 | Early November 2020 | PDF ↗ |
| 26 Aug 2020 | Prednisolone 5mg Suppositories (RPH Pharmaceuticals) | MSAN(2020)83 | Level 2 | Early November 2020 | PDF ↗ |
| 26 Aug 2020 | Diazepam (Diazemuls®) 10mg/2ml emulsion for injection | MSAN(2020)82 | Level 2 | February 2021 | PDF ↗ |
| 26 Aug 2020 | Oral Contraceptive tablets (various brands) | MSAN(2020)81 | Level 2 | Various – see table | PDF ↗ |
| 26 Aug 2020 | H2-antagonists (cimetidine, famotidine and nizatidine) | MSAN(2020)80 | Level 2 | Various dates | PDF ↗ |
| 11 Aug 2020 | Sulfasalazine 250mg/5mL oral suspension (Rosemont) | MSAN(2020)79 | Level 2 | End September 2020 - update to MSAN (2020)31 | PDF ↗ |
| 11 Aug 2020 | Pethidine 50mg tablets | MSAN(2020)78 | Level 2 | TBC | PDF ↗ |
| 05 Aug 2020 | Tuberculosis (TB) oral agents ⚠ | MSAN(2020)77 | Level 2 | Various | PDF ↗ |
| 05 Aug 2020 | H2-antagonists (cimetidine, famotidine and nizatidine) | MSAN(2020)76 | Level 2 | Various dates | PDF ↗ |
| 05 Aug 2020 | Senna with ispaghula husk (Manevac®) granules (Mylan) | MSAN(2020)75 | Level 2 | February 2021 | PDF ↗ |
| 05 Aug 2020 | Nabumetone 500mg Tablets | MSAN(2020)74 | Level 2 | 1st September 2020 | PDF ↗ |
| 27 Jul 2020 | Fluticasone propionate (Flixotide®) 0.5mg/2ml and 2mg/2ml Nebules | MSAN(2020)73 | Level 2 | Mid-December 2020 | PDF ↗ |
| 27 Jul 2020 | Enalapril 20mg tablets (various suppliers) | MSAN(2020)72 | Level 2 | Early August 2020 | PDF ↗ |
| 23 Jul 2020 | Metronidazole (Acea®) 0.75% gel (Ferndale Pharmaceuticals) | MSAN(2020)71 | Level 2 | September 2020 | PDF ↗ |
| 23 Jul 2020 | Ketotifen 1mg/5ml elixir (Zaditen®) | MSAN(2020)70 | Level 2 | TBC | PDF ↗ |
| 23 Jul 2020 | H2-antagonists (cimetidine, famotidine and nizatidine) ⚠ | MSAN(2020)69 | Level 2 | Various dates | PDF ↗ |
| 23 Jul 2020 | Oral Contraceptive tablets (various brands) | MSAN(2020)68 | Level 2 | Various – see table | PDF ↗ |
| 23 Jul 2020 | Hormone Replacement Therapy (all formulations) | MSAN(2020)67 | Level 3 | See table at Annex A | PDF ↗ |
| 13 Jul 2020 | Sodium cromoglicate (Intal®) CFC-free 5mg inhaler (Sanofi) | MSAN(2020)66 | Level 2 | mid-November 2020 | PDF ↗ |
| 13 Jul 2020 | Ferrous Fumarate 322mg/Folic Acid 350microgram (Pregaday®) tablets | MSAN(2020)65 | Level 2 | October 2020 | PDF ↗ |
| 30 Jun 2020 | Fluticasone propionate (Flixotide®) 0.5mg/2ml and 2mg/2ml Nebules | MSAN(2020)64 | Level 2 | 4 November 2020 | PDF ↗ |
| 29 Jun 2020 | Phenelzine (Nardil) 15mg tablets | MSAN(2020)63 | Level 3 | No confirmed resupply date | PDF ↗ |
| 29 Jun 2020 | Prednisolone 5mg Suppositories (RPH Pharmaceuticals) | MSAN(2020)62 | Level 2 | End August 2020 | PDF ↗ |
| 29 Jun 2020 | Promazine 25mg and 50mg tablets | MSAN(2020)61 | Level 2 | w/c 29 June 2020 | PDF ↗ |
| 29 Jun 2020 | Phenytoin sodium NRIM 100mg capsules | MSAN(2020)60 | Level 3 | to be confirmed | PDF ↗ |
| 29 Jun 2020 | H2-antagonists (cimetidine, famotidine and nizatidine) | MSAN(2020)59 | Level 2 | various, see below | PDF ↗ |
| 26 Jun 2020 | Lacosamide (Vimpat®) 50mg tablets (UCB Pharma Ltd) | MSAN(2020)58 | Level 2 | w/c 20 July 2020 | PDF ↗ |
| 26 Jun 2020 | Mirtazapine 15mg and 45mg orodispersible tablets | MSAN(2020)57 | Level 2 | Late July 2020 | PDF ↗ |
| 25 Jun 2020 | Lodoxamide 0.1% (Alomide®) eye drops | MSAN(2020)56 | Level 2 | 24 August 2020 | PDF ↗ |
| 25 Jun 2020 | Imipramine 25mg tablets | MSAN(2020)55 | Level 2 | Early August 2020 | PDF ↗ |
| 23 Jun 2020 | Ranitidine: all formulations ⚠ | MSAN(2020)54 | Level 2 | Various | PDF ↗ |
| 18 Jun 2020 | Tuberculosis (TB) oral agents | MSAN(2020)53 | Level 2 | Various | PDF ↗ |
| 18 Jun 2020 | Levodopa/carbidopa/entacapone tablets - various brands and strengths | MSAN(2020)52 | Level 2 | Early August 2020 | PDF ↗ |
| 11 Jun 2020 | Prednisolone 5mg Suppositories (RPH Pharmaceuticals) | MSAN(2020)51 | Level 2 | End July 2020 | PDF ↗ |
| 01 Jun 2020 | Salazopyrin® (sulfasalazine) 500mg suppositories | MSAN(2020)50 | Level 3 | w/c 15 June 2020 | PDF ↗ |
| 01 Jun 2020 | Promazine 25mg and 50mg tablets | MSAN(2020)49 | Level 2 | mid June 2020 | PDF ↗ |
| 01 Jun 2020 | Valproate semisodium (Depakote®) 250mg and 500mg tablets | MSAN(2020)48 | Level 2 | early July 2020 | PDF ↗ |
| 01 Jun 2020 | H2-antagonists (cimetidine, famotidine and nizatidine) | MSAN(2020)47 | Level 2 | various, see below | PDF ↗ |
| 01 Jun 2020 | Fluoxetine 40mg capsules | MSAN(2020)46 | Level 2 | TBC | PDF ↗ |
| 01 Jun 2020 | Zyban® (bupropion hydrochloride) 150mg prolonged release tablets | MSAN(2020)45 | Level 3 | End November 2020 | PDF ↗ |
| 01 Jun 2020 | Danazol 100mg & 200mg capsules | MSAN(2020)44 | Level 3 | n/a – action to be taken as soon as possible | PDF ↗ |
| 27 May 2020 | Ranitidine: all formulations ⚠ | MSAN(2020)43 | Level 2 | Various | PDF ↗ |
| 20 May 2020 | Tuberculosis (TB) oral agents ⚠ | MSAN(2020)41 | Level 2 | Various | PDF ↗ |
| 18 May 2020 | Cycloserine 250mg capsules | MSAN(2020)42 | Level 2 | TBC | PDF ↗ |
| 14 May 2020 | Salazopyrin® (sulfasalazine) 500mg suppositories | MSAN(2020)40 | Level 3 | 5 June 2020 | PDF ↗ |
| 07 May 2020 | Ranitidine: all formulations ⚠ | MSAN(2020)39 | Level 2 | Various | PDF ↗ |
| 01 May 2020 | Promazine 25mg and 50mg tablets | MSAN(2020)38 | Level 2 | Late May 2020 | PDF ↗ |
| 01 May 2020 | Valproate semisodium (Depakote®) 250mg and 500mg tablets | MSAN(2020)37 | Level 2 | mid May 2020 | PDF ↗ |
| 01 May 2020 | Convulex® (Valproic acid) 150mg, 300mg and 500mg capsules | MSAN(2020)36 | Level 3 | End May 2020 | PDF ↗ |
| 01 May 2020 | Disopyramide 150mg capsules | MSAN(2020)34 | Level 2 | Early May 2020 | PDF ↗ |
| 01 May 2020 | Ativan® (lorazepam) 4mg/mL Solution for injection | MSAN(2020)30 | Level 3 | 19 June 2020 | PDF ↗ |
| 30 Apr 2020 | H2-antagonists (cimetidine, famotidine and nizatidine) | MSAN(2020)35 | Level 2 | various, see below | PDF ↗ |
| 30 Apr 2020 | Salofalk® (mesalazine) 500mg and 1g suppositories – update to MSAN (2020)23 | MSAN(2020)33 | — | End July 2020 | PDF ↗ |
| 30 Apr 2020 | Propantheline bromide (Pro-Banthine) 15mg tablets (Kyowa Kirin) | MSAN(2020)32 | Level 2 | End May 2020 | PDF ↗ |
| 30 Apr 2020 | Sulfasalazine 250mg/5mL oral suspension (Rosemont) | MSAN(2020)31 | Level 2 | End August 2020 | PDF ↗ |
| 23 Apr 2020 | H2-antagonists (cimetidine, famotidine and nizatidine) – update to MSAN | MSAN(2020)25 | — | various, see below | PDF ↗ |
| 20 Apr 2020 | Acetazolamide SR 250mg capsules | MSAN(2020)28 | Level 2 | End July 2020 | PDF ↗ |
| 16 Apr 2020 | Penicillamine 125mg and 250mg tablets | MSAN(2020)27 | — | Late April 2020 | PDF ↗ |
| 16 Apr 2020 | Minims cyclopentolate hydrochloride 0.5% and 1%, eye drops solution | MSAN(2020)26 | — | early April 2020 | PDF ↗ |
| 16 Apr 2020 | DISOPYRAMIDE 150mg TABLETS | MSAN(2020)24 | — | Late April 2020 | PDF ↗ |
| 16 Apr 2020 | Salofalk® (mesalazine) 500mg and 1g suppositories – update to MSAN (2019)12 | MSAN(2020)23 | — | End July 2020 | PDF ↗ |
| 14 Apr 2020 | Diazepam (Diazemuls®) 10mg/2ml emulsion for injection | MSAN(2020)22 | Level 2 | expected September 2020 | PDF ↗ |
| 09 Apr 2020 | Cycloserine 250mg capsules | MSAN(2020)20 | Level 2 | TBC | PDF ↗ |
| 02 Apr 2020 | Stanek® (levodopa/carbidopa/entacapone) tablets - various strength | MSAN(2020)21 | Level 2 | various – see table below | PDF ↗ |
| 16 Mar 2020 | Phenelzine (Nardil) 15mg tablets | MSAN(2020)19 | — | No confirmed resupply date | PDF ↗ |
| 16 Mar 2020 | Fluoxetine 10mg tablets | MSAN(2020)16 | Level 2 | late 2020 | PDF ↗ |
| 16 Mar 2020 | Promazine 25mg and 50mg tablets | MSAN(2020)15 | Level 2 | Mid-April 2020 | PDF ↗ |
| 13 Mar 2020 | Clonidine 25 microgram tablets ⚠ | MSAN(2020)18 | — | End April 2020 | PDF ↗ |
| 13 Mar 2020 | Lorazepam (Ativan®) 4mg/mL injection ⚠ | MSAN(2020)17 | — | w/c 23rd March 2020 | PDF ↗ |
| 12 Mar 2020 | Salofalk® (mesalazine) 500mg and 1g suppositories – update to MSAN (2019)12 | MSAN(2020)14 | Level 2 | mid-September 2020 | PDF ↗ |
| 12 Mar 2020 | Valproate semisodium (Depakote®) 250mg and 500mg tablets | MSAN(2020)13 | Level 2 | Early April 2020 | PDF ↗ |
| 08 Mar 2020 | Docusate sodium 100mg capsules ⚠ | MSAN(2021)9 | Level 2 | June 2021 - update MSAN(2020)119 | PDF ↗ |
| 08 Mar 2020 | Fluoxetine 10mg tablets ⚠ | MSAN(2021)8 | Level 2 | September 2021 - update to MSAN(2020)16 | PDF ↗ |
| 06 Mar 2020 | Salbutamol 2mg/5mL syrup – update to MSAN (2020)5 | MSAN(2020)12 | Level 2 | end March 2020 | PDF ↗ |
| 06 Mar 2020 | H2-antagonists (cimetidine, famotidine and nizatidine) – update to | MSAN(2020)11 | Level 2 | various, see below | PDF ↗ |
| 27 Feb 2020 | Diamorphine Hydrochloride powder for reconstitution and injection 5mg & | MSAN(2020)10 | Level 3 | Spring / Summer 2020 | PDF ↗ |
| 26 Feb 2020 | Epanutin® (phenytoin) 30mg/5mL Oral Suspension | MSAN(2020)9 | Level 3 | 19 June 2020 | PDF ↗ |
| 21 Feb 2020 | Lorazepam (Ativan®) 4mg/mL injection ⚠ | MSAN(2020)8 | Level 2 | w/c 16th March 2020 | PDF ↗ |
| 21 Feb 2020 | Penicillamine 125mg and 250mg tablets | MSAN(2020)7 | Level 2 | Late March 2020 | PDF ↗ |
| 14 Feb 2020 | Levomepromazine 25mg/1mL solution for injection | MSAN(2020)6 | Level 2 | w/c 24 February 2020 | PDF ↗ |
| 12 Feb 2020 | Salbutamol 2mg/5mL syrup | MSAN(2020)5 | Level 2 | end February 2020 | PDF ↗ |
| 29 Jan 2020 | Tuberculosis (TB) oral agents | MSAN(2020)4 | Level 2 | see supporting information at annex A | PDF ↗ |
| 21 Jan 2020 | Hormone Replacement Therapy (all formulations) | MSAN(2020)3 | — | See table at Annex A | PDF ↗ |
| 17 Jan 2020 | Azathioprine 25mg tablets | MSAN(2020)2 | Level 2 | w/c 27 January 2020 | PDF ↗ |
| 10 Jan 2020 | Phenytoin sodium NRIM 100mg capsules | MSAN(2020)1 | Level 3 | 8 May 2020 | PDF ↗ |
| 24 Dec 2019 | Convulex® (Valproic acid) 150mg, 300mg and 500mg capsules | MSAN(2019)31 | Level 3 | 30 April 2020 | PDF ↗ |
| 23 Dec 2019 | Minims cyclopentolate hydrochloride 0.5% and 1%, eye drops solution | MSAN(2019)30 | Level 2 | early January 2020 | PDF ↗ |
| 23 Dec 2019 | H2-antagonists (cimetidine, famotidine and nizatidine) | MSAN(2019)29 | Level 2 | various, see below | PDF ↗ |
| 23 Dec 2019 | Clonidine 25 microgram tablets ⚠ | MSAN(2019)28 | Level 2 | mid-January 2020 | PDF ↗ |
| 18 Dec 2019 | Haloperidol (Serenace®) 500 microgram capsules (Teva) | MSAN(2019)27 | Level 2 | Date to be determined | PDF ↗ |
| 09 Dec 2019 | Benzylpenicillin sodium 1200mg and 600mg powder for injection | MSAN(2019)26 | Level 2 | 16 December 2019 | PDF ↗ |
| 09 Dec 2019 | Midazolam (5mg/ml) 50mg in10ml solution for injection ampoules ⚠ | MSAN(2019)25 | Level 2 | 31 January 2020 | PDF ↗ |
| 02 Dec 2019 | Emerade® 150 microgram, 300 microgram and 500 microgram adrenaline auto- | MSAN(2019)24 | Level 3 | 31 January 2020 | PDF ↗ |
| 28 Nov 2019 | Slo-phyllin® (Theophylline) 60mg/125mg/250mg capsules | MSAN(2019)23 | Level 3 | 28 February 2020 | PDF ↗ |
| 28 Nov 2019 | RANITIDINE ALL FORMULATIONS | MSAN(2019)22 | — | 28 February 2020 | PDF ↗ |
| 22 Nov 2019 | Fluorouracil 5% (Efudix®) cream | MSAN(2019)21 | Level 2 | w/c 16 December 2019 | PDF ↗ |
| 22 Nov 2019 | Reboxetine (Edronax®) 4mg tablets | MSAN(2019)20 | Level 2 | w/c 16 December 2019 | PDF ↗ |
| 20 Nov 2019 | Tuberculosis (TB) oral agents | MSAN(2019)19 | Level 21 | see supporting information at annex A | PDF ↗ |
| 15 Nov 2019 | DISOPYRAMIDE 150mg TABLETS | MSAN(2019)17 | Level 21 | 13 December 2019 | PDF ↗ |
| 15 Nov 2019 | PROVERA® (MEDROXYPROGESTERONE ACETATE) 100mg AND 200mg | MSAN(2019)16 | Level 21 | Ongoing | PDF ↗ |
| 15 Nov 2019 | PETHIDINE 50MG TABLETS | MSAN(2019)15 | Level 21 | early to mid-December 2019 | PDF ↗ |
| 15 Nov 2019 | SYNPHASE® (ETHINYLESTRADIOL AND NORETHISTERONE) TABLETS | MSAN(2019)14 | Level 21 | 20 December 2019 | PDF ↗ |
| 08 Nov 2019 | Medicine in short supply: Procyclidine solution for injection amp 10mg/2ml | MSAN(2019)13 | Level 2 | March 2020 | PDF ↗ |
| 01 Nov 2019 | ______________________ | MSAN(2019)12 | Level 2 | week commencing 16 December 2019 Network | PDF ↗ |
| 01 Nov 2019 | Community Pharmacy Scotland | MSAN(2019)11 | Level 2 | mid-November 2019 | PDF ↗ |
| 01 Nov 2019 | Addressees: | MSAN(2019)10 | — | Ongoing Medicines Shortage Response | PDF ↗ |
| 28 Oct 2019 | Medicine in short supply: Seroxat® (paroxetine) 20mg/10ml For action | MSAN(2019)9 | Level 2 | January 2020 Network | PDF ↗ |
| 28 Oct 2019 | Medicine in short supply: Ongentys® (opicapone) 50mg For action | MSAN(2019)8 | Level 3 | Mid-January 2020 Pharmacists | PDF ↗ |
| 25 Oct 2019 | Addressees: | MSAN(2019)7 | Level 3 | October 2020 Network | PDF ↗ |
| 16 Oct 2019 | ______________________ | MSAN(2019)6 | Level 3 | 15 January 2020 NHS Medical Directors | PDF ↗ |
| 11 Oct 2019 | MEDICINE / DRUG IN SHORT SUPPLY: Detrusitol XL For action | MSAN(2019)5 | Level 2 | 6 December 2019 Network | PDF ↗ |
| 11 Oct 2019 | Medicine/Drug in short supply: Nardil (phenelzine sulfate) For action | MSAN(2019)4 | Level 2 | March 2020 Network | PDF ↗ |
| 23 Sep 2019 | MEDICINE / DRUG IN SHORT SUPPLY: PROVERA® For action | MSAN(2019)2 | Level 2 | 8 November 2019 Pharmacists | PDF ↗ |
| 23 Sep 2019 | MEDICINE / DRUG IN SHORT SUPPLY: FLUOXETINE 10MG, For action ⚠ | MSAN(2019)1 | Level 2 | October – December 2019 (detail below) Pharmacists | PDF ↗ |
| — | 21st January 2025 ⚠ | MSAN(2025)4 | — | 21 February 2025 | PDF ↗ |
| — | Medicine in short supply: Minims phenylephrine 2.5% and 10% w/v eye drops ⚠ | MSAN(2019)18 | Level 3 | January 2020 | PDF ↗ |
| — | Medicine/Drug in short supply: Adrenalin auto-injectors ⚠ | MSAN(2019)3 | — | Ongoing ______________________ | PDF ↗ |